A novel off-the-shelf CAR NK therapy using logic gates has shown complete remissions in relapsed AML patients, according to ...

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours Oslo, Norway, 22 April 2025 – ...

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning ...

More information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Targeted small molecule ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

Detailed price information for Senti Biosciences Inc (SNTI-Q) from The Globe and Mail including charting and trades.

A post hoc analysis shows significantly improved ORR and PFS in advanced NSCLC with higher AFM24 exposure, supporting ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...